Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Nov 2020;13:100252
Detailed outcome-specific results, including effect estimates and stratification by population, are provided in Supplementary Materials 2
This means Canadian patients likely will not have access to prescription Retatrutide through standard healthcare channels until 2027 or 2028
Measurements of worse eyes were used for statistical analysis, i.e., higher pRNFL thickness as a marker of oedema and lower GCL volume as a marker of neuroaxonal loss
Check with your doctor or pharmacist if you are not sure
Moderate-Quality Evidence)
US$ 28.62
US$ 25.83
US$ 24.05
